Omega-3 Fatty Acids in Children and Adolescents With Bipolar Disorder
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the hypothesis that flax oil, as an omega-3 fatty acid,
will be superior to placebo in the maintenance treatment of bipolar disorder in children and
adolescents.
Our primary objective was to determine if flax oil is efficacious in the pediatric bipolar
population for reducing symptoms of mania and depression. A secondary objective was to
examine fatty acid levels as predictors of treatment response and symptom severity. This
clinical trial evaluated whether supplementation with flax oil, containing the omega-3 fatty
acid alpha-linolenic acid (alpha-LNA), safely reduced symptom severity in youth with bipolar
disorder.